Helicos CEO Resigns | GenomeWeb

NEW YORK (GenomeWeb News) – Ivan Trifunovich is leaving Helicos BioSciences, the company disclosed in a document filed with the US Securities and Exchange Commission after the close of the market on Thursday.

Helicos said that Trifunovich is resigning as president and CEO effective Sept. 14 and resigned as executive chairman of Helicos' board on Aug. 31.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.